A Fundamental Problem The opioid crisis has spread like an epidemic across North America. Between January 2016 and March 2019, an estimated 12,800 Canadians died from apparent opioid-related overdoses…
THC
Sector Summary The medical sector is a doozy. From cancer to cardiovascular diseases, areas of high unmet medical need are appearing faster than they can be dealt with. According…
Tetra Bio-Pharma (TBP.T) (“Tetra”) is a biopharmaceutical company focused on cannabinoid-derived drug discovery and development. The Company has an FDA and Health Canada cleared clinical program intended to bring…
In this episode, we take a look at 4 Canadian cannabis stocks with potential. High Tide Cannabis (HITI.V), Heritage Cannabis Holding (CANN.C), Tetra Bio-Pharma (TBP.T) and VIVO Cannabis Inc.,…
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…
Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid…
Xebra Brands Ltd. Xebra Brands Ltd. (“Xebra”) is a cannabis cultivation and product company with global brands and intellectual property. The Company’s focus includes wellness and leisure as well…
Pure Extracts Technologies (PULL.C) subsidiary Pure Extracts Manufacturing shipped its first order of 0.5 gram vape cartridges to its distribution partner, the Alberta Gaming, Liquor and Cannabis (AGLC) today,…
Tetra Bio-Pharma (TBP.T) has announced the start of the REBORN1© clinical trial, designed to evaluate the effect of QIXLEEF™, the Company’s inhaled proprietary drug formulation. During this study, QIXLEEF™…
Tetra Bio-Pharma (TBP.T), a leader in cannabinoid-derived drug discovery and development, announced today that it has been granted a Health Canada Drug Establishment License (DEL) to distribute REDUVO soft…